Sunil Healthcare

{
  "main_header": {
    "sid": 396654,
    "name": "Sunil Healthcare",
    "stock_name": "Sunil Healthcare",
    "full_name": "Sunil Healthcare Ltd",
    "name_url": "stocks-analysis/sunil-healthcare",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "67.78",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "67.78",
    "mcapval": "70.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 537253,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE671C01016",
    "curr_date": "Feb 10",
    "curr_time": "",
    "bse_nse_vol": "7 ",
    "exc_status": "Active",
    "traded_date": "Feb 10, 2026",
    "traded_date_str": "2026 02 10",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sunil-healthcare-396654-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Sunil Healthcare Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-sunil-healthcare-ltd-latest-results-good-or-bad-3826841",
        "imagepath": "",
        "date": "2026-02-07 19:19:13",
        "description": "Sunil Healthcare Ltd has reported its financial results for Q2 FY26, showing a return to profitability with a net profit of ₹1.00 crore, which reflects a quarter-on-quarter increase of 9.89%. The company also achieved net sales of ₹23.52 crores, marking a year-on-year growth of 16.09% and a sequential increase of 3.89%. This marks the third consecutive quarter of revenue growth, indicating a potential stabilization in demand for its gelatin capsule products.\n\nThe operating margin improved to 16.67%, up from 14.49% in the previous quarter, suggesting enhanced operational efficiency. However, the return on equity (ROE) remains low at 2.55%, indicating challenges in capital efficiency. The company is still facing elevated debt levels, with a debt-to-EBITDA ratio averaging 6.68 times, which raises concerns about its ability to manage financial obligations effectively.\n\nDespite these positive indicators, the com..."
      },
      {
        "title": "Sunil Healthcare Q2 FY26: Return to Profitability Masks Underlying Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/sunil-healthcare-q2-fy26-return-to-profitability-masks-underlying-concerns-3825055",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SunilHealthcare_quaterlyResult_3825055.png",
        "date": "2026-02-06 21:01:53",
        "description": "Sunil Healthcare Limited, India's second-largest manufacturer of empty hard gelatin capsule shells, reported a return to profitability in Q2 FY26 with net profit of ₹1.00 crores, marking a significant turnaround from losses in the previous year. However, the micro-cap pharmaceutical company's stock has struggled, trading at ₹69.61 and down 16.13% over the past year, reflecting investor scepticism about the sustainability of this recovery."
      },
      {
        "title": "Sunil Healthcare Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sunil-healthcare-ltd-is-rated-sell-3811059",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SunilHealthcare_mojoScore_3811059.png",
        "date": "2026-01-30 10:11:02",
        "description": "Sunil Healthcare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 14 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Sunil Healthcare Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sunil-healthcare-ltd-is-rated-sell-3793945",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SunilHealthcare_mojoScore_3793945.png",
        "date": "2026-01-19 10:10:46",
        "description": "Sunil Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Sunil Healthcare Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sunil-healthcare-ltd-is-rated-sell-3784336",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SunilHealthcare_mojoScore_3784336.png",
        "date": "2026-01-07 10:10:55",
        "description": "Sunil Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Sunil Healthcare Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sunil-healthcare-ltd-is-rated-sell-3769907",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunilHealthcare_mojoScore_3769907.png",
        "date": "2025-12-25 15:12:04",
        "description": "Sunil Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Why is Sunil Healthcare Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-sunil-healthcare-ltd-fallingrising-3768739",
        "imagepath": "",
        "date": "2025-12-25 01:59:40",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Sunil Healthcare Ltd recorded a gain of ₹2.00 per share, representing a 2.86% increase as of 08:30 PM on 24 December. This rise follows a two-day consecutive upward trend, during which the stock has appreciated by 4.86%. The stock’s intraday high also touched ₹72, signalling strong buying interest during the session. Compared to its sector, the stock outperformed by 3.29% on the day, indicating relative strength amid broader market conditions.</p>\n<p>In the short term, the stock has delivered a 3.09% return over the past week, surpassing the Sensex’s 1.00% gain for the same period. Over the last month, the stock’s 0.70% increase slightly outpaced the Sensex’s 0.60% rise. These figures suggest that Sunil Healthcare is currently exhibiti..."
      },
      {
        "title": "Sunil Healthcare’s Market Assessment Revised Amidst Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sunil-healthcare-downgraded-to-sell-by-marketsmojo-amid-weak-fundamentals-3749934",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunilHealthcare_mojoScore_3749934.png",
        "date": "2025-12-06 10:10:05",
        "description": "Sunil Healthcare has experienced a revision in its market evaluation, reflecting shifts in key analytical parameters that influence investor sentiment. The pharmaceutical and biotechnology microcap’s recent assessment highlights a complex interplay of financial trends, valuation appeal, and technical outlook, set against a backdrop of subdued sector performance and stock returns."
      },
      {
        "title": "Why is Sunil Healthcare falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-sunil-healthcare-fallingrising-3702377",
        "imagepath": "",
        "date": "2025-11-14 22:06:59",
        "description": "As of 14-Nov, Sunil Healthcare Ltd's stock price is currently at 72.00, reflecting an increase of 0.27 (0.38%). The stock has recently experienced a trend reversal, gaining after five consecutive days of decline. However, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally bearish trend. Despite this, the company has reported positive financial results, including a 9.89% growth in net profit and strong operating cash flow, which may have contributed to the recent uptick in stock price. Nonetheless, the stock has underperformed significantly over the past year, with a return of -5.26%, and has shown weak long-term fundamental strength, including a low return on capital employed and poor sales growth.\n\nIn the broader market context, the stock's performance over the past week has been notably poor, with a decline of 4.38%, while the benchmark Sensex has i..."
      }
    ],
    "total": 93,
    "sid": "396654",
    "stock_news_url": "https://www.marketsmojo.com/news/sunil-healthcare-396654"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "08-Feb-2026",
      "details": "Newspaper clippings regarding publication of un-audited financial results for 3rd quarter/9 months ended 31st December 2025 (both standalone and consolidated)",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Financial Results (Both Standalone And Consolidated) For The Quarter And Nine Months Ended 31.12.2025 Of FY 2025-26",
      "datetime": "06-Feb-2026",
      "details": "Board at its meeting held today interalia approved Unaudited Financial Results (both standalone and consolidated) for the quarter and nine months ended 31.12.2025 of FY 2025-26",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On 06.02.2026",
      "datetime": "06-Feb-2026",
      "details": "Pursuant to Regulation 30 of the SEBI (LODR) Regulations 2015 we are pleased to inform that the Board of Directors of the Company at their Board Meeting held on Friday February 06 2026 interalia approved Un-Audited Financial Results (standalone and consolidated) for the 3rd quarter/ nine months ended December 31 2025 of the FY 2025-26.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Sunil Healthcare Ltd latest results good or bad?

2026-02-07 19:19:13

Sunil Healthcare Ltd has reported its financial results for Q2 FY26, showing a return to profitability with a net profit of ₹1.00 crore, which reflects a quarter-on-quarter increase of 9.89%. The company also achieved net sales of ₹23.52 crores, marking a year-on-year growth of 16.09% and a sequential increase of 3.89%. This marks the third consecutive quarter of revenue growth, indicating a potential stabilization in demand for its gelatin capsule products. The operating margin improved to 16.67%, up from 14.49% in the previous quarter, suggesting enhanced operational efficiency. However, the return on equity (ROE) remains low at 2.55%, indicating challenges in capital efficiency. The company is still facing elevated debt levels, with a debt-to-EBITDA ratio averaging 6.68 times, which raises concerns about its ability to manage financial obligations effectively. Despite these positive indicators, the com...

Read full news article

Sunil Healthcare Q2 FY26: Return to Profitability Masks Underlying Concerns

2026-02-06 21:01:53

Sunil Healthcare Limited, India's second-largest manufacturer of empty hard gelatin capsule shells, reported a return to profitability in Q2 FY26 with net profit of ₹1.00 crores, marking a significant turnaround from losses in the previous year. However, the micro-cap pharmaceutical company's stock has struggled, trading at ₹69.61 and down 16.13% over the past year, reflecting investor scepticism about the sustainability of this recovery.

Read full news article

Sunil Healthcare Ltd is Rated Sell

2026-01-30 10:11:02

Sunil Healthcare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 14 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Sunil Healthcare Ltd is Rated Sell

2026-01-19 10:10:46

Sunil Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Sunil Healthcare Ltd is Rated Sell

2026-01-07 10:10:55

Sunil Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Sunil Healthcare Ltd is Rated Sell

2025-12-25 15:12:04

Sunil Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Why is Sunil Healthcare Ltd falling/rising?

2025-12-25 01:59:40

Recent Price Movement and Market Context

Sunil Healthcare Ltd recorded a gain of ₹2.00 per share, representing a 2.86% increase as of 08:30 PM on 24 December. This rise follows a two-day consecutive upward trend, during which the stock has appreciated by 4.86%. The stock’s intraday high also touched ₹72, signalling strong buying interest during the session. Compared to its sector, the stock outperformed by 3.29% on the day, indicating relative strength amid broader market conditions.

In the short term, the stock has delivered a 3.09% return over the past week, surpassing the Sensex’s 1.00% gain for the same period. Over the last month, the stock’s 0.70% increase slightly outpaced the Sensex’s 0.60% rise. These figures suggest that Sunil Healthcare is currently exhibiti...

Read full news article

Sunil Healthcare’s Market Assessment Revised Amidst Challenging Fundamentals

2025-12-06 10:10:05

Sunil Healthcare has experienced a revision in its market evaluation, reflecting shifts in key analytical parameters that influence investor sentiment. The pharmaceutical and biotechnology microcap’s recent assessment highlights a complex interplay of financial trends, valuation appeal, and technical outlook, set against a backdrop of subdued sector performance and stock returns.

Read full news article

Why is Sunil Healthcare falling/rising?

2025-11-14 22:06:59

As of 14-Nov, Sunil Healthcare Ltd's stock price is currently at 72.00, reflecting an increase of 0.27 (0.38%). The stock has recently experienced a trend reversal, gaining after five consecutive days of decline. However, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally bearish trend. Despite this, the company has reported positive financial results, including a 9.89% growth in net profit and strong operating cash flow, which may have contributed to the recent uptick in stock price. Nonetheless, the stock has underperformed significantly over the past year, with a return of -5.26%, and has shown weak long-term fundamental strength, including a low return on capital employed and poor sales growth. In the broader market context, the stock's performance over the past week has been notably poor, with a decline of 4.38%, while the benchmark Sensex has i...

Read full news article

View All News